Company Valuation: Emcure Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026 2027 2028
Capitalization 1 2,03,202 2,76,497 - -
Change - 36.07% - -
Enterprise Value (EV) 1 2,08,106 2,83,239 2,78,620 2,70,003
Change - 36.1% -1.63% -3.09%
P/E ratio 29.4x 28.6x 24x 19.6x
PBR 4.57x 5.16x 4.33x 3.62x
PEG - 0.7x 1.3x 0.9x
Capitalization / Revenue 2.57x 3.02x 2.67x 2.39x
EV / Revenue 2.64x 3.1x 2.7x 2.33x
EV / EBITDA 14.2x 15.9x 13.4x 11.1x
EV / EBIT 19.2x 20.7x 16.9x 13.7x
EV / FCF 33x 35.2x 24.2x 21.6x
FCF Yield 3.03% 2.84% 4.13% 4.63%
Dividend per Share 2 3 3.078 3.704 4.513
Rate of return 0.28% 0.21% 0.25% 0.31%
EPS 2 36.43 50.96 60.7 74.33
Distribution rate 8.23% 6.04% 6.1% 6.07%
Net sales 1 78,960 91,438 1,03,373 1,15,640
EBITDA 1 14,689 17,830 20,823 24,277
EBIT 1 10,847 13,709 16,494 19,671
Net income 1 6,813 9,628 11,472 14,051
Net Debt 1 4,904 6,742 2,122 -6,494
Reference price 2 1,072.40 1,458.40 1,458.40 1,458.40
Nbr of stocks (in thousands) 1,89,483 1,89,590 - -
Announcement Date 22/05/25 - - -
1INR in Million2INR
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
28.22x3.06x15.67x0.21% 294.76Cr
28.95x10.91x21.91x0.67% 88TCr
25.63x5.96x16.23x2.19% 58TCr
24x6.55x13.15x3.16% 39TCr
17.32x4.22x10.43x3.13% 32TCr
23.94x4.98x13.83x1.75% 30TCr
20.93x5.64x13.96x2.87% 29TCr
27.02x4.74x14.82x2.92% 29TCr
24.64x6.26x11.14x2.74% 20TCr
20.1x6.12x11.06x2.25% 18TCr
Average 24.07x 5.84x 14.22x 2.19% 34.29TCr
Weighted average by Cap. 24.73x 6.94x 15.71x 2.11%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. EMCURE Stock
  4. Valuation Emcure Pharmaceuticals Limited
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW